← Back to patent-cliff list
CAS 2685871-36-5
1-(Bromomethyl)-5-chloro-2-ethoxy-4-nitrobenzene
Codes: Mosapride Citrate-075
Application context (from source-drug indications)
GastritisMosapride CitrateEnteral feeding intoleranceMosapride CitrateIrritable bowel syndromeMosapride CitrateDyspepsiaMosapride CitrateConstipationMosapride Citrate
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Mosapride Citrate | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
1-Chloro-2-methylbenzene→2-Chloro-1-methyl-4-nitrobenzene→Potassium ethanolate→2-Ethoxy-1-methyl-4-nitrobenzene→1-(Bromomethyl)-2-ethoxy-4-nitrobenzene→1-(Bromomethyl)-5-chloro-2-ethoxy-4-nitrobenzene→1-Chloro-4-ethoxy-5-(methoxymethyl)-2-nitrobenzene→2-Chloro-5-ethoxy-4-(methoxymethyl)aniline→[4-(4-Fluorobenzyl)-2-morpholinyl]methylamine→Mosapride Citrate-007
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.